Advertisement
Canada markets open in 20 minutes
  • S&P/TSX

    21,656.05
    +13.18 (+0.06%)
     
  • S&P 500

    5,022.21
    -29.20 (-0.58%)
     
  • DOW

    37,753.31
    -45.66 (-0.12%)
     
  • CAD/USD

    0.7273
    +0.0009 (+0.12%)
     
  • CRUDE OIL

    83.07
    +0.38 (+0.46%)
     
  • Bitcoin CAD

    85,621.38
    -12.34 (-0.01%)
     
  • CMC Crypto 200

    885.54
    0.00 (0.00%)
     
  • GOLD FUTURES

    2,402.30
    +13.90 (+0.58%)
     
  • RUSSELL 2000

    1,947.95
    -19.53 (-0.99%)
     
  • 10-Yr Bond

    4.5980
    +0.0130 (+0.28%)
     
  • NASDAQ futures

    17,681.25
    +22.75 (+0.13%)
     
  • VOLATILITY

    17.91
    -0.30 (-1.65%)
     
  • FTSE

    7,858.49
    +10.50 (+0.13%)
     
  • NIKKEI 225

    38,079.70
    +117.90 (+0.31%)
     
  • CAD/EUR

    0.6816
    +0.0014 (+0.21%)
     

Abbott's Sales and Earnings Are Sinking: Should Investors Worry?

Abbott's Sales and Earnings Are Sinking: Should Investors Worry?

Abbott (NYSE: ABT) reported its full-year and fourth-quarter results for 2022 on Wednesday. Abbott's bad news definitely jumped out. While Abbott's sales fell 12% on a reported basis, the year-over-year decline was only 6.1% excluding the impact of foreign exchange.